Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-29

FDA Approved: LEFLUNOMIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Leflunomide (generic) submitted by Chartwell RX, LLC under an ANDA, enabling market authorization of a generic Leflu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

SUPPL AP for LEFLUNOMIDE (LEFLUNOMIDE)